Premarket Mover: Achilles Therapeutics PLC (ACHL) Up 1.64%

Achilles Therapeutics PLC (ACHL) is higher by Friday morning, with the stock increasing 1.64% in pre-market trading to 1.24. ACHL's short-term technical score of 53 indicates that the stock has traded more bullishly over the last month than 53% of stocks on the market. In the Biotechnology industry, which ranks 88 out of 146 industries, ACHL ranks higher than 60% of stocks. Achilles Therapeutics PLC has risen 32.61% over the past month, closing at $0.94 on February 9. During this period of time, the stock fell as low as $0.94 and as high as $1.76. ACHL has an average analyst recommendation of Buy. The company has an average price target of $6.50.

ACHL has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on ACHL!

See Full ACHL Report

Achilles Therapeutics PLC has a Long-Term Technical rank of 84. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 16% of the market scoring higher. In the Biotechnology industry which is number 49 by this metric, ACHL ranks better than 49% of stocks.

Important Dates for Investors in ACHL:

-Achilles Therapeutics PLC is set to release earnings on 2024-06-03. Over the last 12 months, the company has reported EPS of $-1.90. -We do not have a set dividend date for Achilles Therapeutics PLC at this time. Click Here To Get The Full Report on Achilles Therapeutics PLC (ACHL)